TP53 and neoplasm: To explore the contribution of common ccRCC driver mutations (such as VHL, TP53, BAP1, PBRM1, and SETD2) in case #22, four different areas of the primary tumor were analyzed by WES and compared to its derivative cell line (Fig. 1e).